KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to -$4.1 million.

  • Vertex Pharmaceuticals' Exchange Rate Effect fell 11798.25% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year increase of 1308.41%. This contributed to the annual value of -$42.6 million for FY2024, which is 25836.43% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Exchange Rate Effect stood at -$4.1 million, which was down 11798.25% from $57.2 million recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Exchange Rate Effect ranged from a high of $57.2 million in Q2 2025 and a low of -$47.3 million during Q4 2024
  • Over the past 5 years, Vertex Pharmaceuticals' median Exchange Rate Effect value was -$4.0 million (recorded in 2021), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Exchange Rate Effect plummeted by 74750.0% in 2022, and later skyrocketed by 238800.0% in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Exchange Rate Effect stood at -$4.9 million in 2021, then surged by 932.65% to $40.8 million in 2022, then tumbled by 32.84% to $27.4 million in 2023, then tumbled by 272.63% to -$47.3 million in 2024, then skyrocketed by 91.33% to -$4.1 million in 2025.
  • Its Exchange Rate Effect stands at -$4.1 million for Q3 2025, versus $57.2 million for Q2 2025 and $30.5 million for Q1 2025.